fMRI responses to words repeated in a congruous semantic context are abnormal in mild Alzheimer's disease

John M Olichney1, Jason R Taylor, Shiaohui Chan

  • 1Department of Neurology, University of California, Davis, Davis, CA 95618-5412, USA. jmolichney@ucdavis.edu

Neuropsychologia
|May 4, 2010
PubMed
Abstract

Insights

Early Alzheimer's disease (AD) impairs brain networks involved in word repetition, showing reduced responses in mild AD patients compared to controls. This suggests functional MRI can detect early AD-related changes in verbal encoding.

Area of Science:

  • Neuroimaging
  • Cognitive Neuroscience
  • Neurology

Background:

  • An event-related brain potential word repetition paradigm, sensitive to early Alzheimer's disease (AD), was adapted for functional MRI (fMRI).
  • Early AD is hypothesized to be associated with reduced differential brain response to new versus old congruous words.

Purpose of the Study:

  • To investigate functional MRI (fMRI) differences in brain activity between mild Alzheimer's disease (AD) patients and normal elderly individuals using a word repetition paradigm.
  • To identify brain regions and networks associated with verbal encoding and their dysfunction in early AD.

Main Methods:

  • Fifteen mild AD patients and 15 normal elderly controls underwent 1.5T fMRI during a semantic category decision task.
  • Analysis focused on Blood-Oxygen-Level-Dependent (BOLD) responses to congruous words, comparing new versus old stimuli (New>Old contrast) and old versus new stimuli (Old>New contrast).

Main Results:

  • Robust group differences in BOLD response to congruous words were observed.
  • In controls, New>Old responses were prominent in the left hemisphere, including areas associated with P600 generation (parahippocampal, cingulate, fusiform, perirhinal, middle temporal, and inferior frontal gyri).
  • Mild AD patients showed significantly fewer New>Old responses, primarily in the right hemisphere, indicating dysfunction in the left-hemisphere network crucial for verbal encoding.

Conclusions:

  • A distributed left-hemisphere network, including P600 generators, is vital for successful verbal encoding in normal elderly individuals.
  • This network appears dysfunctional in mild AD patients, evidenced by decreased word repetition effects, particularly in left association cortex, paralimbic, and medial temporal lobe structures.
  • fMRI adaptation of the word repetition paradigm effectively detects early AD-related neural deficits in verbal memory processes.

Related Concept Videos

Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...